2023
Factors associated with receiving results and attending colposcopy in patients with positive HPV screens in Mexico City
León-Maldonado L, Hernández-Ramírez R, Torres-Ibarra L, Spiegelman D, Sheth S, Lazcano E, Cadena-Fiscal J, Salmerón J. Factors associated with receiving results and attending colposcopy in patients with positive HPV screens in Mexico City. Preventive Medicine Reports 2023, 35: 102347. PMID: 37593354, PMCID: PMC10428024, DOI: 10.1016/j.pmedr.2023.102347.Peer-Reviewed Original ResearchPercent of participantsColposcopy appointmentHealthcare facilitiesHigh-risk human papillomavirusMultivariable logistic regressionHealthcare system factorsScreening resultsPositive screening resultsColposcopy adherenceColposcopy clinicHPV screenPrevious PapMedian ageCervical cancerPap testHuman papillomavirusHigh school educationPatientsGreater adherenceExperienced nursesGood complianceLogistic regressionScheduling appointmentsLimited staff availabilityAdherenceValidation of the Cancer Stigma Scale in Nepalese Women
Shrestha A, Stangl A, Paneru B, Poudel L, Karmacharya A, Makaju S, Spiegelman D, Shakya S, Shrestha A, Sheth S. Validation of the Cancer Stigma Scale in Nepalese Women. Asian Pacific Journal Of Cancer Prevention 2023, 24: 204-214. PMID: 36708569, PMCID: PMC10152840, DOI: 10.31557/apjcp.2023.24.1.207.Peer-Reviewed Original ResearchConceptsCancer Stigma ScaleCancer stigmaCancer patientsStigma ScaleCronbach's alphaNepali womenInternal consistencyCross-cultural adaptationNepalese populationNepalese womenSufficient internal consistencyCancerWomenPatientsSatisfactory internal reliabilityVulnerable groupsAlphaInternal reliabilityStigmaOverall scaleModel fit indicesHigh levelsSix-factor structure
2022
Diet- and Lifestyle‐Based Prediction Models to Estimate Cancer Recurrence and Death in Patients With Stage III Colon Cancer (CALGB 89803/Alliance)
Cheng E, Ou FS, Ma C, Spiegelman D, Zhang S, Zhou X, Bainter TM, Saltz LB, Niedzwiecki D, Mayer RJ, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Giovannucci EL, Van Blarigan EL, Brown JC, Ng K, Gross CP, Meyerhardt JA, Fuchs CS. Diet- and Lifestyle‐Based Prediction Models to Estimate Cancer Recurrence and Death in Patients With Stage III Colon Cancer (CALGB 89803/Alliance). Journal Of Clinical Oncology 2022, 40: 740-751. PMID: 34995084, PMCID: PMC8887946, DOI: 10.1200/jco.21.01784.Peer-Reviewed Original ResearchMeSH KeywordsAgedAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantColonic NeoplasmsDietFemaleFollow-Up StudiesHumansLife StyleMaleMiddle AgedModels, StatisticalMulticenter Studies as TopicNeoplasm Recurrence, LocalNomogramsPrognosisRandomized Controlled Trials as TopicRisk FactorsSurvival RateConceptsStage III colon cancerDisease-free survivalLifestyle factorsSelf-reported dietPathologic featuresColon cancerPathologic characteristicsMultivariable Cox proportional hazards regressionCox proportional hazards regressionAdjuvant chemotherapy trialsProportional hazards regressionPredictive survivalChemotherapy trialsDFS eventsOverall survivalSurvival prediction modelHazards regressionSurvival outcomesVisual nomogramLifestyle habitsPatient outcomesCancer recurrenceLifestyle exposuresPatientsCancer
2014
Who are they? Identifying risk factors of loss to follow up among HIV+ patients on care and treatment in Dar es Salaam
Machumi L, Mtisi E, Andrew I, Sando D, Mkali H, Liu E, Hertzmark E, Spiegelman D, Fawzi W, Chalamilla G. Who are they? Identifying risk factors of loss to follow up among HIV+ patients on care and treatment in Dar es Salaam. BMC Infectious Diseases 2014, 14: p78. PMCID: PMC4221014, DOI: 10.1186/1471-2334-14-s2-p78.Peer-Reviewed Original Research
2013
Micronutrient supplementation and T cell-mediated immune responses in patients with tuberculosis in Tanzania
KAWAI K, MEYDANI SN, URASSA W, WU D, MUGUSI FM, SAATHOFF E, BOSCH RJ, VILLAMOR E, SPIEGELMAN D, FAWZI WW. Micronutrient supplementation and T cell-mediated immune responses in patients with tuberculosis in Tanzania. Epidemiology And Infection 2013, 142: 1505-1509. PMID: 24093552, PMCID: PMC5639693, DOI: 10.1017/s0950268813002495.Peer-Reviewed Original ResearchConceptsCell-mediated immune responsesTB patientsMicronutrient supplementationMicronutrient supplementsImmune responseProliferative responseT cell-mediated immune responsesHIV-negative TB patientsHIV-positive TB patientsLymphocyte proliferative responsesLymphocyte proliferation responseHigher proliferative responsesT cell mitogensPlacebo groupPulmonary TBTB treatmentDaily doseEligible participantsNutritional interventionTuberculosis treatmentTime of initiationClinical relevanceMicronutrient groupProliferation responsePatients
2012
Perceptions, Facilitators, and Barriers to Consumption of Whole Grain Staple Foods among Overweight and Obese Tanzanian Adults: A Focus Group Study
Muhihi A, Shemaghembe E, Njelekela M, Gimbi D, Mwambene K, Malik V, Wedick N, Spiegelman D, Hu F, Willett W. Perceptions, Facilitators, and Barriers to Consumption of Whole Grain Staple Foods among Overweight and Obese Tanzanian Adults: A Focus Group Study. International Scholarly Research Notices 2012, 2012: 1-7. DOI: 10.5402/2012/790602.Peer-Reviewed Original ResearchUnrefined carbohydratesDiet-related chronic diseasesFocus group discussionsEnergy-dense foodsTanzanian adultsObese adultsDiabetic patientsRefined carbohydratesChronic diseasesHigh intakeFocus group studyGroup studyMost participantsWhole grainsOverweightCultural acceptabilityKey facilitatorsAdultsParticipantsQSR N6 softwareFacilitatorsEducational strategiesPatientsFoodGroup discussions
2011
Anemia in TB patients predicts recurrence and mortality
Isanaka S, Mugusi F, Urassa W, Bosch R, Villamor E, Spiegelman D, Duggan C, Fawzi W. Anemia in TB patients predicts recurrence and mortality. The FASEB Journal 2011, 25: 779.14-779.14. DOI: 10.1096/fasebj.25.1_supplement.779.14.Peer-Reviewed Original ResearchTreatment failureIron deficiencyHypochromic microcytosisHIV-TB patientsCause of anemiaPoor clinical outcomeRisk of recurrenceMeasures of anemiaTuberculosis recurrenceHIV patientsTB patientsClinical outcomesSevere anemiaRisk factorsAnemiaOverall healthPatientsRecurrenceMortalityRiskMicrocytosisSignificant improvementAssociationDeficiencyFocused management
2004
Understanding the Role of HIV Load in Determining Weight Change in the Era of Highly Active Antiretroviral Therapy
Mwamburi DM, Wilson IB, Jacobson DL, Spiegelman D, Gorbach SL, Knox TA, Wanke CA. Understanding the Role of HIV Load in Determining Weight Change in the Era of Highly Active Antiretroviral Therapy. Clinical Infectious Diseases 2004, 40: 167-173. PMID: 15614708, DOI: 10.1086/426591.Peer-Reviewed Original ResearchConceptsActive antiretroviral therapyVirus loadBody weightAntiretroviral therapyHIV infectionWeight changeStudy visitHuman immunodeficiency virus RNA loadHighly Active Antiretroviral TherapyAbsence of HAARTProspective cohort studyCell count decreaseVirus RNA loadTime of enrollmentStudy intervalRepeated-measures analysisHIV loadHAART useCohort studyRNA loadHAARTPatientsEligible sampleCell countCount decrease
2003
High-fiber diet in HIV-positive men is associated with lower risk of developing fat deposition
Hendricks KM, Dong KR, Tang AM, Ding B, Spiegelman D, Woods MN, Wanke CA. High-fiber diet in HIV-positive men is associated with lower risk of developing fat deposition. American Journal Of Clinical Nutrition 2003, 78: 790-795. PMID: 14522738, DOI: 10.1093/ajcn/78.4.790.Peer-Reviewed Original ResearchConceptsHIV-positive patientsFat depositionFood recordsDietary fiberHealthy Living cohortPast dietary intakeHIV-positive menCase-control studyOverall energy intakeWilcoxon rank sum testHigh-fiber dietRank sum testLiving cohortCurrent smokersDietary intakeResistance trainingLower riskEnergy intakePatientsUnhealthy behaviorsHealthy lifestyleHIVDietary componentsGreater intakeHigh-quality diet
2002
Changes in lean body mass and total body weight are weakly associated with physical functioning in patients with HIV infection
Wilson I, Jacobson D, Roubenoff R, Spiegelman D, Knox T, Gorbach S. Changes in lean body mass and total body weight are weakly associated with physical functioning in patients with HIV infection. HIV Medicine 2002, 3: 263-270. PMID: 12444944, DOI: 10.1046/j.1468-1293.2002.00122.x.Peer-Reviewed Original ResearchConceptsTotal body weightSelf-reported physical functioningPhysical functioningHIV infectionBody weightRelationship of changesCells/ micro l.Mean CD4 countHIV-positive personsMain outcome measuresLean body massLongitudinal analysisCD4 countCohort studyPositive personsOutcome measuresHealthy personsBody compositionPatientsStudy designWeight lossMicro l.InfectionWomenHealthy living
2001
Patterns of Adherence With Antiretroviral Medications: An Examination of Between-Medication Differences.
Wilson IB, Tchetgen E, Spiegelman D. Patterns of Adherence With Antiretroviral Medications: An Examination of Between-Medication Differences. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2001, 28: 259. PMID: 11694833, DOI: 10.1097/00042560-200111010-00009.Peer-Reviewed Original ResearchConceptsAntiretroviral medicationsAdherence issuesPatient differencesLast weekMore antiretroviral medicationsPercent of patientsPatterns of adherencePatient adherence issuesRepeated-measurements analysisCohort studyHIV infectionAntiretroviral adherenceAdherence ratesMean ageOverall adherenceMedicationsPatientsAdherence patternsPerfect adherencePerson varianceDosing timeAdherenceWeeksDoseReliability coefficientsPatterns of Adherence With Antiretroviral Medications: An Examination of Between-Medication Differences
Wilson I, Tchetgen E, Spiegelman D. Patterns of Adherence With Antiretroviral Medications: An Examination of Between-Medication Differences. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2001, 28: 259-263. DOI: 10.1097/00126334-200111010-00009.Peer-Reviewed Original ResearchAntiretroviral medicationsAdherence issuesPatient differencesLast weekMore antiretroviral medicationsPercent of patientsPatterns of adherencePatient adherence issuesRepeated-measurements analysisCohort studyHIV infectionAntiretroviral adherenceAdherence ratesMean ageOverall adherenceMedicationsPatientsAdherence patternsPerfect adherencePerson varianceDosing timeAdherenceWeeksDoseReliability coefficients
1998
The effect of protease inhibitors on weight and body composition in HIV-infected patients
Silva M, Skolnik P, Gorbach S, Spiegelman D, Wilson I, Fernández-DiFranco M, Knox T. The effect of protease inhibitors on weight and body composition in HIV-infected patients. AIDS 1998, 12: 1645-1651. PMID: 9764784, DOI: 10.1097/00002030-199813000-00012.Peer-Reviewed Original ResearchConceptsLean body massPI therapyHIV infectionWeight gainViral loadPhysical functioningHealth perceptionBody compositionCurrent health perceptionsActive antiretroviral therapyPI treatmentProtease inhibitor therapyBody mass indexGreater weight gainHuman growth hormoneAntiretroviral therapyHIV cohortBody massInhibitor therapyMass indexOptimal therapyFat massAnabolic stimuliPatientsGrowth hormone
1997
Risk Factors for Postherpetic Neuralgia
Choo PW, Galil K, Donahue JG, Walker AM, Spiegelman D, Platt R. Risk Factors for Postherpetic Neuralgia. JAMA Internal Medicine 1997, 157: 1217-1224. PMID: 9183233, DOI: 10.1001/archinte.1997.00440320117011.Peer-Reviewed Original ResearchConceptsOnset of zosterPostherpetic neuralgiaRisk factorsHerpes zosterCases of PHNTreatment of zosterHealth maintenance organizationSystemic acyclovirSystemic corticosteroidsElderly patientsPharmacy recordsCommon complicationSensory symptomsProdromal symptomsHigh prevalenceZosterEligibility criteriaMaintenance organizationPatientsPrevalenceTreatment factorsCorticosteroidsNeuralgiaAcyclovirSymptomsAdverse Outcomes of Underuse of β-Blockers in Elderly Patients-Reply
Soumerai S, McLaughlin T, Spiegelman D, Hertzmark E, Thibault G, Goldman L. Adverse Outcomes of Underuse of β-Blockers in Elderly Patients-Reply. JAMA 1997, 277: 1436-1437. DOI: 10.1001/jama.1997.03540420032022.Peer-Reviewed Original ResearchCalcium channel blockersChannel blockersΒ-blockersNondihydropyridine calcium channel blockersNational evidence-based guidelinesDihydropyridine calcium channel blockerΒ-blocker useAdministrative claims databaseLipid-lowering agentsEvidence-based guidelinesEffective drug classClaims databaseAdverse outcomesDrug classesComparative efficacyBlockersCommunity settingsPatients' repliesAspirinPrevious reportsUnderuseOutcomesPatientsTrials